Serina Therapeutics, Inc.SERNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank11
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-16.51M
↓ 104% vs avg
Percentile
P11
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-8.11M
Historical baseline
PeriodValueYoY Change
TTM$-16.51M+3.7%
2024$-17.14M-592.1%
2023$-2.48M-19.3%
2022$-2.08M+7.8%
2021$-2.25M+71.2%
2020$-7.82M+23.1%
2019$-10.16M-27.1%
2018$-8.00M-27.2%
2017$-6.29M+25.4%
2016$-8.43M-